Franklin M. Berger, Director at Kezar Life Sciences, Inc. (KZR), bought 80,000 shares at $14.77 ($1.3M) on 2022-03-21, disclosed to the SEC on 2022-03-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.96 | 15,000 | $239K | 18.4% |
| 2 | $17.00 | 45,000 | $765K | 58.9% |
| 3 | $14.77 | 20,000 | $295K | 22.7% |
| Total | $16.25 avg | 80,000 | $1.3M | 100% |
| Filing → |
| EPIX | BUY | 2023-11-22 | $267K | — | Filing → |
| EPIX | BUY | 2023-11-16 | $518K | — | Filing → |
| EPIX | SELL | 2023-01-05 | $1.0M | — | Filing → |